Healthcare marketing Q&A · ICG Editorial

What claims does the Drugs and Magic Remedies Act ban in healthcare ads?

The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 bans ads that claim a drug or remedy treats, cures or prevents the diseases listed in its Schedule, improves sexual capacity, procures miscarriage or prevents conception, or corrects menstrual disorders. It also bans misleading drug claims and any "magic remedy" ad. As of October 2026, it applies to pharma, nutraceutical, ayurveda and clinic ads alike. Confirm specific claims with your counsel.

What does the Drugs and Magic Remedies Act actually ban?

The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 bans ads that promote a drug, remedy or "magic remedy" for certain purposes. These include treating conditions listed in its Schedule, improving sexual capacity, procuring miscarriage or preventing conception, and correcting menstrual disorders. It also bans false or misleading claims about any drug.

The full text is on India Code, the Government of India's official legal database. As of October 2026, the main provisions work like this:

Section	What it covers	What it means for an ad
Section 3	Ads for drugs for specified purposes, including conditions in the Schedule and sexual capacity	No ad may suggest a product treats, cures or prevents a scheduled condition
Section 4	Misleading ads about drugs	No false impression about the true character of a drug, and no false claims
Section 5	Magic remedies	No ads for talismans, mantras, charms or similar items claimed to have miraculous powers to cure or treat
Section 7	Penalties	Imprisonment, fine or both, with a higher term for repeat convictions

The Schedule lists conditions such as cancer, diabetes, epilepsy, obesity, high blood pressure and sexual impotence. Read the current Schedule before you write any claim that names a disease. Amendments have been proposed over the years, so check the version in force with counsel.

Which healthcare ad claims cross the line?

Any claim that a product cures, treats or prevents a scheduled condition crosses it. So do "permanent cure", "guaranteed results", "no side effects" and "doctor-approved miracle" claims for a drug or remedy. The Act focuses on drugs and remedies, so nutraceutical, ayurveda and D2C wellness brands carry the highest exposure.

"Reverses diabetes in weeks" on a supplement pack or ad.
"Ayurvedic cure for obesity" in a Meta campaign.
"Restores sexual stamina naturally" in any channel.
Before-and-after weight-loss claims tied to a product.

Clinics are not off the hook. A clinic ad that sells a "cure" through its own branded medicine or kit is promoting a drug. Clinics that employ doctors also face the NMC's 6 October 2026 guidelines, which restrict claims and inducements in promotion. ICG's NMC compliance audit checks both layers on your website and social handles.

For D2C brands, our deeper piece on the DMR Act for D2C healthcare brands walks through product-page copy.

What are ads in pharma, and how are they regulated?

Pharma ads are any promotion of a drug, device or health product to doctors, chemists or the public. In India, prescription drugs generally cannot be advertised to the public under the drug laws. Promotion to healthcare professionals is governed by the Uniform Code for Pharmaceutical Marketing Practices 2024, and public-facing claims also sit under the DMR Act and the ASCI code.

In practice, pharma marketing in India splits into three lanes:

HCP marketing. Medical representatives, scientific content, CMEs and digital detailing to doctors. UCPMP 2024 restricts gifts, hospitality and unsubstantiated claims.
OTC and consumer health. Products sold without prescription can be advertised to the public, but claims must avoid scheduled conditions and must not mislead.
Disease awareness. Unbranded education about a condition, without naming or implying a prescription product.

ICG's pharma marketing services are built around these three lanes.

What makes the most popular pharmaceutical ads work?

Memorable pharma and consumer-health ads tend to lead with a relatable everyday moment, a single clear benefit within the law, and a recognisable brand cue. They do not rely on cure claims. Memorable creative and compliant claims are not in conflict; strong campaigns get both right.

For a brand team, the checklist is short. Lead with the situation, not the disease name. Make one claim you can substantiate. Keep the brand visible early. Run every script past regulatory review before production, not after.

Can doctors advertise in India?

Only within narrow limits. As of October 2026, individual doctors may share genuinely educational content in their own name, with qualifications and registration number. Hospitals and clinics may publish factual, verifiable information. Testimonials, before-and-after images, inducements and "best" or "No. 1" claims are not allowed in promotion.

The DMR Act adds a further layer. A doctor who endorses a remedy with a cure claim for a scheduled condition may breach both the Act and the NMC rules. ICG works on a compliance-first marketing model so that content is reviewed against both before it goes live. This is general information; confirm specific cases with your counsel.

Detailed answers

Yes. The Act covers any "drug", which it defines broadly to include substances for internal or external use in the diagnosis, treatment or prevention of disease. Ayurvedic, herbal and nutraceutical products that make disease claims fall within it. Brands in these categories carry high exposure because their ads often name conditions such as diabetes or obesity.

Section 7 provides for imprisonment, a fine or both, with a longer maximum term for a subsequent conviction. The exact terms are in the Act on India Code, the official legal database. Beyond the penalty, a breach can also trigger action under consumer law and, for doctors, the NMC rules. Ask counsel for the current position.

A clinic can describe a service factually, such as a diabetes clinic or a weight-management consultation. What it cannot do is claim a drug or remedy treats or cures a scheduled condition. Keep copy to who you see, what the consultation involves and how to book, and avoid outcome promises.

It is risky. A blanket "no side effects" claim is rarely provable and can be read as a false or misleading claim under Section 4 of the DMR Act. It may also breach the ASCI code and the CCPA 2022 guidelines on misleading advertising. Replace it with accurate, substantiated information about the product.

There is no single pre-approval body for most healthcare ads. Advertisers are responsible for their own claims. ASCI handles complaints, the CCPA can act on misleading ads, officers authorised by state governments, usually in the drug control department, enforce the DMR Act, and the NMC oversees doctors. That is why an internal review step before launch matters.

Ready to move?

Book a free 30-minute Brand & Growth Diagnostic.

It's a working session, not a sales pitch — you leave with a written root-cause analysis you can act on, whether or not you engage ICG.

Book free diagnostic → See ICG's compliance-first healthcare marketing → WhatsApp ICG →